By indication / Parkinsonian syndromes and movement disorders
Parkinsonian syndromes and movement disorders
14 imaging agents and 0 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Syntheses |
|---|---|---|---|
| [18F]FDOPA | F-18 | Approved | 49 |
| [123I]MIBG paired with [131I]MIBG | I-123 | — | 33 |
| [123I]FP-CIT | I-123 | Approved | 8 |
| [18F]FE-PE2I | F-18 | — | 5 |
| [123I]iodoamphetamine | I-123 | — | 5 |
| [18F]FP-CIT | F-18 | — | 3 |
| [11C]ER176 | C-11 | — | 1 |
| [18F]FDDNP | F-18 | — | 1 |
| [18F]FMN3PU | F-18 | preclinical | 1 |
| [18F]PBR06 | F-18 | — | 1 |
| [18F]SMBT-1 | F-18 | — | 1 |
| [18F]pi2620 | F-18 | — | |
| [18F]ro948 | F-18 | — | |
| [123I]R91150 | I-123 | — |
Therapy
Nothing indexed under this heading yet.
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region — tell us what you need.
Get in touch